Skip to main content
See every side of every news story
Get Started
SubscribeLogin
Published • loading... • Updated

HIV Prevention Vaginal Ring Withdrawn From FDA Consideration

Summary by Ground News
The International Partnership for Microbicides pulled its application for FDA approval for the pre-exposure prophylaxis (PrEP) ring. That leaves cisgender women with two HIV prevention options. The daily pill, first approved in 2012, is now generic but previously sold as Truvada.

1 Articles

MedscapeMedscape

HIV Prevention Vaginal Ring Withdrawn From FDA Consideration

One year after the World Health Organization recommended a vaginal ring to protect women from HIV following years of research — some done in the US — the ring will not be coming to US clinics. Here's why.

·New York, United States
Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

Medscape broke the news in New York, United States on Tuesday, January 25, 2022.
Too Big Arrow Icon
Sources are mostly out of (0)
Blindspot Title And Logo
Stories disproportionately reported by the Left or the Right

Similar News Topics

Medical icon

Medical

News
Feed Dots Icon
For You
Search Icon
SearchBlindspot LogoBlindspotLocal